⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

ALMR

Alamar Biosciences, Inc.

Healthcare · Medical Devices

30.69USD

+0.9700 (+3.26%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ALMR.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 30.69
P/E—
Dvd Ind Yld0.0%
P/B6.81
P/S25.1
Curr EV/T12M EBITDA-51.5
Mkt Cap (USD)2.1B
Curr EV (USD)1.9B
2)

Per Share Data

EPS T12M-3.26
DPS—
Bk Val Per Sh4.51
Rev/Sh1.44
Cash/Sh3.60
Curr Shares Out69.4M
FCF/Sh-1.06
3)

Cash Flow Analysis

P/CF-37.6
Curr P/FCF-34.3
CF/NI1.2
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-66.8%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr—
Cap 1Y Gr-19.1%
BPS 1Y Gr—
R&D To Sales52.0%
Retention Rate—
Rev 1Y Gr—
FCF 1Y Gr—
Assets 1Y Gr—
5)

Profitability

EBITDA-0.0B
EBIT-0.0B
Operating Margin-50.0%
Pretax Margin-57.6%
Net Margin-58.1%
ROA-12.6%
ROE-57.0%
ROC—
Asset Turnover0.22
6)

Structure

Current Ratio11.85
Quick Ratio9.67
Debt/Assets13.1%
Debt/Com Eq16.4%
Net Debt/EBITDA2.13
Tot Debt/Capital14.1%
Gross Margin55.7%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.